Investors in GoodRx Holdings, Inc. Alerted to Class Action Lawsuit by Levi & Korsinsky, LLP

Investors who have experienced financial losses with their investment in GoodRx Holdings, Inc. (GDRX), the U.S.-based company known for its prescription price comparison platform, have been notified of a class action lawsuit seeking recovery of their losses. The legal firm Levi & Korsinsky, LLP, headquartered in New York, announced the suit, which pertains to certain activities related to securities of GoodRx Holdings, Inc.

Details of the Class Action Suit

Levi & Korsinsky, LLP is spearheading the lawsuit, focusing on investors who may have been affected adversely by potential misrepresentations or misleading statements from GoodRx. The class action aims to compile claims from various investors who have purchased or otherwise acquired shares of GoodRx (GDRX) and subsequently faced monetary losses. Interested parties are being urged to join the class action to collectively seek recompense for their investments' devaluation.

Company Profile of GoodRx Holdings, Inc.

With its headquarters in Santa Monica, California, GoodRx Holdings, Inc. offers a crucial service in the healthcare market, providing tools and information to U.S. consumers for comparing prices across pharmacies and saving money on prescription medications. The platform's utility in facilitating consumer savings on prescriptions has made it integral to many individuals managing healthcare costs effectively.

lawsuit, investment, recovery